Oligonucleotide NX1838 inhibits VEGF165-mediated cellular responses in vitro

In Vitro Cellular and Developmental Biology - Animal

Volumn 35, Issue 9, 1999, Pages 533-542

  Bell, Carol ^a   Lynam, Eric ^a   Landfair, Darla J ^a   Janjic, Nebojsa ^a   Wiles, Marc E ^a  

^a GILEAD SCIENCES   (United States)

Author keywords

Cell signaling; Oligonucleotide; Signal transduction; VEGF

Indexed keywords

OLIGONUCLEOTIDE; PEGAPTANIB; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CALCIUM MOBILIZATION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PHASE 1 CLINICAL TRIAL; PROTEIN PHOSPHORYLATION; PSORIASIS; RETINA MACULA DEGENERATION; SIGNAL TRANSDUCTION;

EID: 0032707345     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-999-0064-y     Document Type: Article

References (45)

1. Berridge, M. J. Inositol triphosphate and calcium signalling. Nature (Lond) 361:315-325; 1993.
2. Brown, L. F.; Detmar, M.; Claffey, K.; Nagy, J. A.; Feng, D.; Dvorak, A. M.; Dvorak, H. F. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. Exper. Suppl. (Basel) 79:233-269; 1997.
3. Claffey, K. P.; Robinson, G. S. Expression of vascular permeability factor/ vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res. 56:172-181; 1996.
4. Claffey, K. P.; Wilkison, W. O.; Spiegelman, B. M. Vascular endothelial growth factor: regulation by cell differentiation and activated second messenger pathways. J. Biol. Chem. 267:16317-16321; 1992.
5. Clauss, M.; Gerlach, M.; Gerlach, H.; Brett, J.; Wang, F.; Familletti, P. C.; Pan, Y. C.; Olander, J. V.; Connolly, D. T.; Stern, D. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J. Exp. Med. 172:1535-1545; 1990.
6. Clauss, M.; Weich, H.; Breier, G.; Knies, U.; Rockl, W.; Waltenberger, J.; Risau, W. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J. Biol. Chem. 271:17629-17634; 1996.
7. Conn, G.; Soderman, D. D.; Shaeffer, M.-T.; Wile, M.; Hatcher, V. B.; Thomas, K. A. Amino acid and cDNA sequences of a vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc. Natl. Acad. Sci. USA 87:1323-1327; 1990.
8. D'Angelo, G.; Lee, H.; Weiner, R. I. cAmp-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation. J. Cell. Biochem. 67:353-366; 1997.
9. D'Angelo, G.; Struman, I.; Martial, J.; Weiner, R. I. Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin. Proc. Natl. Acad. Sci. USA 92:6374-6378; 1995.
10. deVries, C.; Escobendo, J. A.; Ueno, H.; Houck, K.; Ferrara, N.; Williams, L. T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science (Wash DC) 255:989-991; 1992.
11. Eriksson, A.; Rorsman, C.; Ernlund, A.; Claesson-Welsh, L.; Heldin, C. H. Ligand-induced homo- and hetero-dimerization of platelet-derived growth factor alpha- and beta-receptors in intact cells. Growth Factors 6:1-14; 1992.
12. Ferrara, N.; Houck, K. A.; Jakeman, L. B.; Winer, J.; Leung, D. W. The vascular endothelial growth factor family of polypeptides. J. Cell. Biochem. 47:211-218; 1991.
13. Fukumura, D.; Xavier, R.; Sugiura, T.; Chen, Y.; Park, E. C.; Lu, N.; Selig, M.; Nielsen, G.; Taksir, T.; Jain, R. K.; Seed, B. Tumor induction of VEGF promoter activity in stromal cells. Cell 94:715-725; 1998.
14. Gitay-Goren, H.; Soker, S.; Vlodavsky, I.; Neufeld, G. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J. Biol. Chem. 267:6093-6098; 1992.
15. Green, L. S.; Jellinek, D.; Bell, C.; Beebe, L. A.; Feistner, B. D.; Gill, S. C.; Jucker, F. M.; Janjic, N. Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor. Chem. Biol. 2:683-695; 1995.
16. Heldin, C.-H. Dimerization of cell surface receptors in signal transduction. Cell 80:213-223; 1995.
17. Hill, C. S.; Treisman, R. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80:199-211; 1995.
18. Jellinek, D.; Green, L. S.; Bell, C.; Janjic, N. Inhibition of receptor binding by high-affinity RNA ligands to vascular endothelial growth factor. Biochemistry 33:10450-10456; 1994.
19. Kanakaraj, P.; Raj, S.; Khan, S. A.; Bishayee, S. Ligand-induced interaction between alpha- and beta-type platelet-derived growth factor (PEGF) receptors: role of receptor heterodimers in kinase activation. Biochemistry 30:1761-1767; 1991.
20. Kanner, S. B.; Grosmaire, L. S.; Ledbetter, J. A.; Damle, N. K. Beta 2-integrin LFA-1 signaling through phospholipase C-gamma 1. Proc. Natl. Acad. Sci. USA 90:7099-7103; 1993.
21. Kendall, R. L. and Thomas, K. A. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl. Acad. Sci. USA 90:10705-10709; 1993.
22. Keyt, B. A.; Berleau, L. T.; Nguyen, H. V.; Chen, H.; Heinsohn, H.; Vandlen, R.; Ferrara, N. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J. Biol. Chem. 271:7788-7795; 1996.
23. Koch, A. E.; Harlow, L. A.; Haines, G. K.; Amento, E. P.; Unemori, E. N.; Wong, W. L.; Pope, R. M.; Ferrara, N. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J. Immunol. 152:4149-4156; 1994.
24. Leung, D. W.; Cachianes, G.; Guang, W. J.; Goeddel, D. V.; Ferrara, N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (Wash DC) 246:1306-1309; 1989.
25. Millauer, B.; Wizigman-Voos, S.; Schnurch, H.; Martinez, R.; Moller, N. P. H.; Risau, W.; Ullrich, A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835-846; 1993.
26. Motulsky, H. Intuitive biostatistics. New York: Oxford University Press; 1995.
27. Nemerson, Y. Tissue factor and hemostasis. Blood. 71:1-8; 1988.
28. Omura, T.; Miyazawa, K.; Ostman, A.; Heldin, C. H. Identification of a 190-kDa vascular endothelial growth factor 165 cell surface binding protein on a human glioma cell line. J. Biol. Chem. 272:23317-23322; 1997.
29. Park, J. E.; Keller, G. A.; Ferrara, N. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol. Biol. Cell. 4:1317-1326; 1993.
30. Plate, K. H.; Breier, G.; Weich, H. A.; Risau, W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature (Lond) 359:845-848; 1992.
31. Ruckman, J.; Green, L. S.; Beeson, J.; Waugh, S.; Gillette, W. L.; Henninger, D. D.; Claesson-Welsh, L.; Janjic, N. 2′-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. J. Biol. Chem. 273:20556-20567; 1998.
32. Schlessinger, J. Direct binding and activation of receptor tyrosine kinases by collagen. Cell 91:869-872; 1997.
33. Senger, D. R.; Claffey, K. P.; Benes, J. E.; Perruzzi, C. A.; Sergiou, A. P.; Detmar, M. Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc. Natl. Acad. Sci. USA 94:13612-13617; 1997.
34. Senger, D. R.; Galli, S. J.; Dvorak, A. M.; Perruzzi, C. A.; Harvey, V. S.; Dvorak, H. F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (Wash DC) 219:983-985; 1983.
35. Sioussat, T.; Dvorak, H. F.; Brock, T. A.; Senger, D. R. Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies. Arch. Biochem. Biophys. 301:15-20; 1993.
36. Soker, S.; Fidder, H.; Neufeld, G.; Klagsbrun, M. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain. J. Biol. Chem. 271:5761-5767; 1996.
37. Soker, S.; Gollamudi-Payne, S.; Fidder, H.; Charmahelli, H.; Klagsbrun, M. Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial cell proliferation by a peptide corresponding to the exon 7-encoded domain of VEGF165. J. Biol. Chem. 272:31582-31588; 1997.
38. Soker, S.; Takashima, S.; Miao, H. Q.; Neufeld, G.; Klagsbrun, M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92:735-745; 1998.
39. Strawn, L. M.; McMahon, G.; App, H.; Schreck, R.; Kuchler, W. R.; Longhi, M. P.; Hui, T. H.; Tang, C.; Levitzki, A.; Gazit, A.; Chen, I.; Keri, G.; Orfi, L.; Risau, W.; Flamme, I.; Ullrich, A.; Hirth, K. P.; Shawver, L. K. Flk-1 as a target for tumor growth inhibition. Cancer Res. 56:3540-3545; 1996.
40. Takahashi, T.; Shibuya, M. The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts. Oncogene 14:2079-2089; 1997.
41. Terman, B. I.; Dougher-Vermazen, M. Biological properties of VEGF/VPF receptors. Cancer Metastasis Rev. 15:159-163; 1996.
42. Terman, B. I.; Dougher-Vermazen, M.; Carrion, M. E.; Dimitrov, D.; Armellino, D. C.; Gospodarowicz, D.; Bohlen, P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem. Biophys. Res. Commun. 187:1579-1586; 1992.
43. Tuerk, C. and Gold, L.; Systematic evolution of ligands by exponential enrichment: RNA ligands. Science (Wash DC) 249:505-510; 1990.
44. Vaisman, N.; Gospodarowicz, D.; Neufeld, G. Characterization of the receptors for vascular endothelial growth factor. J. Biol. Chem. 265:19461-19466; 1990.
45. Waltenberger, J.; Claesson-Welsh, L.; Siegbahn, A.; Shibuya, M.; Heldin, C.-H. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem. 269:26988-26995; 1994.